159 related articles for article (PubMed ID: 2221710)
1. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
[TBL] [Abstract][Full Text] [Related]
2. [Hemorheological changes in retinal vein occlusions].
Peduzzi M; Debbia A; Guerrieri F; Zirilli E; Bolzani R; Barbieri U
Ric Clin Lab; 1985; 15 Suppl 1():321-6. PubMed ID: 4035223
[TBL] [Abstract][Full Text] [Related]
3. [Increase of erythrocyte aggregation in retinal vein occlusion].
Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
[TBL] [Abstract][Full Text] [Related]
4. [Hemorrheologic disorders in obese patients. Study of the viscosity of the blood, erythrocytes, plasma, fibrinogen and the erythrocyte filtration index].
Craveri A; Tornaghi G; Paganardi L; Ranieri R; Leonardi G; Di Bella M
Minerva Med; 1987 Jul; 78(13):899-906. PubMed ID: 3601135
[TBL] [Abstract][Full Text] [Related]
5. Role of haemorheological factors in patients with retinal vein occlusion.
Sofi F; Mannini L; Marcucci R; Bolli P; Sodi A; Giambene B; Menchini U; Gensini GF; Abbate R; Prisco D
Thromb Haemost; 2007 Dec; 98(6):1215-9. PubMed ID: 18064316
[TBL] [Abstract][Full Text] [Related]
6. [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
Glacet-Bernard A; Coscas G; Lelong F; Chabanel A; Samama M; Taccoen A
Bull Soc Ophtalmol Fr; 1989 Dec; 89(12):1393-6. PubMed ID: 2632113
[TBL] [Abstract][Full Text] [Related]
7. Type of arteriovenous crossing at site of branch retinal vein occlusion.
Sekimoto M; Hayasaka S; Setogawa T
Jpn J Ophthalmol; 1992; 36(2):192-6. PubMed ID: 1513066
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors and visual prognosis of 407 patients with retinal vein occlusion].
Zhang HR; Xia YJ
Zhonghua Yan Ke Za Zhi; 1991 Sep; 27(5):271-4. PubMed ID: 1815918
[TBL] [Abstract][Full Text] [Related]
9. Central retinal vein occlusion in two patients with immunoglobulin G multiple myeloma associated with blood hyperviscosity.
Hayasaka S; Ugomori S; Kodama T; Noda S; Setogawa T
Ann Ophthalmol; 1993 May; 25(5):191-4. PubMed ID: 8517591
[TBL] [Abstract][Full Text] [Related]
10. [Factor VIII/Ag (von Willebrand) and protein C. Erythrocyte deformability and aggregability. The risk parameters of retinal vein occlusion].
Cortinovis A; Crippa A; Crippa M
Minerva Med; 1994 May; 85(5):211-9. PubMed ID: 8028749
[TBL] [Abstract][Full Text] [Related]
11. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
[TBL] [Abstract][Full Text] [Related]
12. Blood viscosity in proliferative diabetic retinopathy and complicated retinal vein thrombosis.
Trope GE; Lowe GD; Ghafour IM; Foulds WS; Forbes CD
Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():108-10. PubMed ID: 6197788
[TBL] [Abstract][Full Text] [Related]
13. [Effect of hemodilution on retinal hemodynamics in retinal branch vein occlusion].
Remky A; Wolf S; Hamid M; Bertram B; Schulte K; Arend O; Reim M
Ophthalmologe; 1994 Jun; 91(3):288-92. PubMed ID: 7522064
[TBL] [Abstract][Full Text] [Related]
14. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
[TBL] [Abstract][Full Text] [Related]
15. [Hemorheologic factors in hypertensive and diabetic retinopathy].
Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B
Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065
[TBL] [Abstract][Full Text] [Related]
16. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of resistance to APC in young patients with retinal vein occlusion.
Kuhli C; Hattenbach LO; Scharrer I; Koch F; Ohrloff C
Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
Lip PL; Blann AD; Jones AF; Lip GY
Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
[TBL] [Abstract][Full Text] [Related]
19. [Retinal vein occlusion and lipoprotein (a)].
Ribeaudeau-Saindelle F; Glacet-Bernard A; Lelong F; Coscas G; Soubrane G
J Fr Ophtalmol; 1998 Apr; 21(4):245-50. PubMed ID: 9759412
[TBL] [Abstract][Full Text] [Related]
20. [Effect of "Yiqi yangyin huoxue" prescription on hemorrheology of diabetics with symptoms of "qi, yin" deficiency and stasis of blood].
Liang XC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Apr; 11(2):87-91. PubMed ID: 2528425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
